Form 8-K - Current report:
SEC Accession No. 0001493152-25-017627
Filing Date
2025-10-09
Accepted
2025-10-09 17:04:00
Documents
21
Period of Report
2025-10-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58629
2 EX-1.1 ex1-1.htm EX-1.1 142637
3 EX-5.1 ex5-1.htm EX-5.1 19883
4 EX-10.1 ex10-1.htm EX-10.1 237758
5 EX-99.1 ex99-1.htm EX-99.1 13503
6 EX-99.2 ex99-2.htm EX-99.2 13135
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3235
8 GRAPHIC ex99-1_001.jpg GRAPHIC 20854
9 GRAPHIC ex99-2_001.jpg GRAPHIC 20854
  Complete submission text file 0001493152-25-017627.txt   862296

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE biaf-20251008.xsd EX-101.SCH 3768
11 XBRL DEFINITION FILE biaf-20251008_def.xml EX-101.DEF 26601
12 XBRL LABEL FILE biaf-20251008_lab.xml EX-101.LAB 36623
13 XBRL PRESENTATION FILE biaf-20251008_pre.xml EX-101.PRE 25225
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5766
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251385761
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)